Cargando…
Use of a High-Purity Factor X Concentrate in Turkish Subjects with Hereditary Factor X Deficiency: Post Hoc Cohort Subanalysis of a Phase 3 Study
Hereditary factor X (FX) deficiency is a rare bleeding disorder more prevalent in countries with high rates of consanguineous marriage. In a prospective, open-label, multicenter phase 3 study, 25 IU/kg plasma-derived factor X (pdFX) was administered as on-demand treatment or short-term prophylaxis f...
Autores principales: | Öner, Ahmet F., Celkan, Tiraje, Timur, Çetin, Norton, Miranda, Kavaklı, Kaan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Galenos Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5972335/ https://www.ncbi.nlm.nih.gov/pubmed/29545231 http://dx.doi.org/10.4274/tjh.2017.0446 |
Ejemplares similares
-
Plasma‐derived factor X concentrate compassionate use for hereditary factor X deficiency: Long‐term safety and efficacy in a retrospective data‐collection study
por: Huang, James N., et al.
Publicado: (2021) -
A review of the pharmacokinetics, efficacy and safety of high‐purity factor X for the prophylactic treatment of hereditary factor X deficiency
por: Payne, Jeanette, et al.
Publicado: (2022) -
Rare Coagulation Disorders: A Retrospective Analysis of 156 Patients in Turkey
por: Fışgın, Tunç, et al.
Publicado: (2012) -
Analysis of Chromosomal Aberrations and FLT3 gene Mutations in Childhood Acute Myelogenous Leukemia Patients
por: Coşkunpınar, Ender, et al.
Publicado: (2012) -
What does a hemogram say to us?
por: Celkan, Tülin Tiraje
Publicado: (2020)